2014
DOI: 10.1016/j.mimet.2014.02.011
|View full text |Cite
|
Sign up to set email alerts
|

Performance of a multiplexed serological microarray for the detection of antibodies against central nervous system pathogens

Abstract: Central nervous system (CNS) infections have multiple potential causative agents for which simultaneous pathogen screening can provide a useful tool. This study evaluated a multiplexed microarray for the simultaneous detection of antibodies against CNS pathogens. The performance of selected microarray antigens for the detection of IgG antibodies against herpes simplex virus 1 and 2 (HSV-1 and HSV-2), varicella-zoster virus (VZV), adenovirus, Mycoplasma pneumoniae and Borrelia burgdorferi sensu lato, was evalua… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2015
2015
2019
2019

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 33 publications
0
1
0
Order By: Relevance
“…Protein microarrays are miniaturized versions of traditional assays enabling high-throughput parallel detection of multiple biomarkers in serum samples or other specimens of interest in a single assay (1). To survey seroprevalence of virus-specific antibodies, simultaneous detection of antibodies against multiple viruses is also advantageous, and high-throughput serodiagnostic microarray platforms are under active development for many infectious diseases (26).…”
Section: Introductionmentioning
confidence: 99%
“…Protein microarrays are miniaturized versions of traditional assays enabling high-throughput parallel detection of multiple biomarkers in serum samples or other specimens of interest in a single assay (1). To survey seroprevalence of virus-specific antibodies, simultaneous detection of antibodies against multiple viruses is also advantageous, and high-throughput serodiagnostic microarray platforms are under active development for many infectious diseases (26).…”
Section: Introductionmentioning
confidence: 99%